Escitalopram in the treatment of major depressive disorder: A meta-analysis

By Kennedy Sidney H.   Andersen Henning F.   Thase Michael E.  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 161-175

Informa Healthcare

Access to resources Recommend Favorite

A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms

By Gaynor Paula J.   Gopal Murali   Zheng Wei   Martinez James M.   Robinson Michael J.   Marangell Lauren B.  

Current Medical Research and Opinion, Vol. 27, Iss. 10, 2011-10 ,pp. : 1849-1858

Informa Healthcare

Access to resources Recommend Favorite

The relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorder

By Fishbain David A.   Detke Michael J.   Wernicke Joachim   Chappell Amy S.   Kajdasz Daniel K.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3105-3115

Informa Healthcare

Access to resources Recommend Favorite

TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META‐ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS

By  

DEPRESSION AND ANXIETY (ELECTRONIC), Vol. 1091-4269, Iss. 10, 2015-10 ,pp. : 763-773

John Wiley & Sons Inc

Access to resources Recommend Favorite

TYPE 2 DIABETES IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A META‐ANALYSIS OF PREVALENCE ESTIMATES AND PREDICTORS

By  

DEPRESSION AND ANXIETY (ELECTRONIC), Vol. 32, Iss. 10, 2015-10 ,pp. : 763-773

John Wiley & Sons Inc

Access to resources Recommend Favorite